Hepatic Arterial Infusion Chemotherapy
8 clinical trials · Condition
◉ Watch Hepatic Arterial Infusion Chemotherapy
| Record | Firm | Date |
|---|---|---|
| Effect of Esketamine on Abdominal Pain During TACE-HAIC in Patients With Hepatocellular Carcinoma (NCT05416073) | The Second Affiliated Hospital of Chongqing Medical University | 2022-06-22 |
| cTACE or DEB-TACE+HAIC Combined With Regorafenib ± Anti-PD1 Antibody for uHCC (NCT05025592) | Peking University Cancer Hospital & Institute | 2021-09-10 |
| HAIC in Combination With PD-1 Inhibitors and Lenvatinib for High Tumor Burden Advanced HCC (CHANCE2416) (NCT06631326) | First Hospital of China Medical University | 2021-01-01 |
| HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma (NCT06333561) | Sun Yat-sen University | 2021-01-01 |
| HAIC Combined Sintilimab for Liver Metastasis From Esophageal Squamous Cell Carcinoma (NCT06184841) | Peking University Cancer Hospital & Institute | 2020-06-18 |
Track Hepatic Arterial Infusion Chemotherapy automatically
Every clearance here is in the API, with alerts when new ones post.